Compositions and methods of mechanically inducing tissue regeneration

Patent metadata

Field	Value
Publication number	US-11197944-B2
Application number	US-201615776853-A
Country	US
Kind code	B2
Filing date	Nov 18, 2016
Priority date	Nov 18, 2015
Publication date	Dec 14, 2021
Grant date	Dec 14, 2021

Abstract

The present invention provides methods and compositions for promoting regeneration of a tissue, methods for preventing or reducing inflammation of a tissue, methods for preventing or reducing fibrosis of a tissue, methods for increasing a mass of a tissue, methods for increasing a level of oxygen available to a tissue, methods for increasing a rate of metabolic waste removal from a tissue, methods for increasing blood perfusion to a tissue, and methods of treating severe muscle tissue damage in a subject in need thereof by contacting the tissue with a composition that is suitable for applying cyclic mechanical compression to the tissue.

First claim

We claim:

1. A method for promoting regeneration of a tissue in a subject in need thereof, comprising:
contacting the tissue with a composition comprising a matrix material and a magnetic material distributed therethrough, wherein the composition comprises macropores having a mean pore diameter in the range of about 10 μm to about 10000 μm, wherein the magnetic material is in the form of magnetic particles having a size in the range from about 1 nm to about 500 nm, and wherein porosity, pore size, pore connectivity, and/or specific volume of the composition changes by at least 10% in response to an electromagnetic signal; and
applying cyclic mechanical compressions to the tissue, thereby promoting regeneration of the tissue,
wherein the composition is free of a bioactive agent, a therapeutic agent, a cell, or a combination thereof.

2. The method of claim 1 , wherein the cyclic mechanical compressions are caused by the electromagnetic signal, or by pneumatic or hydraulic actuation.

3. The method of claim 1 , wherein the composition comprises a swelling agent, wherein the swelling agent concentration changes by at least 10% in response to an electromagnetic signal.

4. The method of claim 1 , wherein the composition has a porosity of 0.1 to 0.99.

5. The method of claim 1 , wherein the matrix material is a polymer, a cross-linked polymer, a copolymer, or a block polymer gel.

6. The method of claim 1 , wherein the matrix material comprises a polymer selected from the group consisting of polyurethanes, glycosaminoglycan, silk, fibrin, poly-ethyleneglycol (PEG), polyhydroxy ethyl methacrylate, polyvinyl alcohol, polyacrylamide, poly (N-vinyl pyrolidone), poly(lactic acid), poly glycolic acid (PGA), poly lactic-co-glycolic acid (PLGA), poly e-carpolactone (PCL), polyethylene oxide, poly propylene fumarate (PPF), poly acrylic acid (PAA), polyhydroxybutyric acid, hydrolysed polyacrylonitrile, polymethacrylic acid, polyethylene amine, esters of alginic acid; pectinic acid; alginate, fully or partially oxidized alginate, hyaluronic acid, carboxy methyl cellulose, heparin, heparin sulfate, chitosan, carboxymethyl chitosan, chitin, pullulan, gellan, xanthan, collagen, gelatin, carboxymethyl starch, carboxymethyl dextran, chondroitin sulfate, cationic guar, cationic starch, and combinations thereof.

7. The method of claim 1 , wherein the magnetic material is ferromagnetic, ferrimagnetic, diamagnetic, paramagnetic, or superparamagnetic material.

8. The method of claim 1 , wherein the macropores have a mean pore diameter in the range of about 150 μm to about 7500 μm.

9. The method of claim 1 , wherein porosity, pore size, pore connectivity, swelling agent concentration, and/or specific volume changes by at least 25% in response to the electromagnetic signal.

10. The method of claim 1 , wherein the magnetic material is distributed homogeneously within the matrix material.

11. The method of claim 1 , wherein the magnetic material is distributed heterogeneously within the matrix material.

12. The method of claim 11 , wherein the heterogeneous distribution of the magnetic material within the matrix material is formed by application of a magnetic field during polymerization of the matrix material.

13. The method of claim 11 , wherein the magnetic material is distributed into a separate compartment within the matrix material or is distributed at one side within the matrix material distant from the electromagnetic signal.

14. The method of claim 1 , wherein the composition is suitable for implantation within the tissue.

15. The method of claim 1 , wherein the tissue is damaged and the cyclic mechanical compressions are applied to the site of tissue damage (i) within less than 5, 10, 20, 30, 40, 50, 60 minutes after the damage has occurred; (ii) at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, or 24 hours after the damage has occurred; (iii) at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 days or at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 11, 12, 24, 48 or 60 months after the damage has occurred; (iv) over a period of at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 24, 36, 48, 60, 72, 84, 96 or 120 hours; (v) over a period of at least 14 days; or (vi) for about 1 to 30 days, about 1 to 50 days, about 1 to 100 days, about 1 to 200 days or about 1 to 300 days.

Assignees

• Harvard College
• Charite—Universitaetsmedizin Berlin
• Univ Berlin Charite

Inventors

• Cezar Christine A
• Walsh Conor J
• Mooney David J
• Roche Ellen T
• Vandenburgh Herman H
• Duda Georg N

Classifications

• A61L27/50

  Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title

• A61K47/36

  Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin · CPC title

• A61L27/14

  Macromolecular materials · CPC title

• A61L27/56

  Porous materials, {e.g. foams or sponges} · CPC title

• A61L27/54

  Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title